BBIO(BBIO)
BBIO
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $969M | $1.59B | $2.44B | $3.50B | $4.47B |
| Low | $939M | $1.36B | $2.43B | $3.09B | $3.95B |
| High | $1.00B | $1.81B | $2.44B | $3.96B | $5.07B |
| EBITDA Avg | $-969M | $-1.59B | $-2.44B | $-3.50B | $-4.47B |
| Low | $-1.00B | $-1.81B | $-2.44B | $-3.96B | $-5.07B |
| High | $-939M | $-1.36B | $-2.43B | $-3.09B | $-3.95B |
| EBIT Avg | $-969M | $-1.59B | $-2.44B | $-3.50B | $-4.47B |
| Low | $-1.00B | $-1.81B | $-2.44B | $-3.96B | $-5.07B |
| High | $-939M | $-1.36B | $-2.43B | $-3.09B | $-3.95B |
| Net Income Avg | $-434M | $74M | $703M | $1.47B | $1.99B |
| Low | $-597M | $-1.07B | $-4M | $1.25B | $1.69B |
| High | $-278M | $1.74B | $1.35B | $1.73B | $2.34B |
| EPS Avg | $-2.17 | $0.54 | $3.67 | $7.47 | $10.09 |
| Low | $-3.03 | $-5.40 | $-0.02 | $6.33 | $8.56 |
| High | $-1.41 | $8.81 | $6.84 | $8.77 | $11.84 |
| Analysts (Rev / EPS) | 17 / 13 | 15 / 12 | 16 / 14 | 15 / 8 | 15 / 12 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $221M | $255M | $295M | $307M | $350M | $405M | $462M | $485M |
| Low | $217M | $248M | $273M | $284M | $324M | $374M | $427M | $448M |
| High | $228M | $265M | $351M | $365M | $416M | $481M | $549M | $576M |
| EBITDA Avg | $-221M | $-255M | $-295M | $-307M | $-350M | $-405M | $-462M | $-485M |
| Low | $-228M | $-265M | $-351M | $-365M | $-416M | $-481M | $-549M | $-576M |
| High | $-217M | $-248M | $-273M | $-284M | $-324M | $-374M | $-427M | $-448M |
| EBIT Avg | $-221M | $-255M | $-295M | $-307M | $-350M | $-405M | $-462M | $-485M |
| Low | $-228M | $-265M | $-351M | $-365M | $-416M | $-481M | $-549M | $-576M |
| High | $-217M | $-248M | $-273M | $-284M | $-324M | $-374M | $-427M | $-448M |
| Net Income Avg | $-114M | $-92M | $-59M | $-42M | $-11M | $30M | $71M | $138M |
| Low | $-157M | $-135M | $-74M | $-52M | $-14M | $27M | $64M | $124M |
| High | $-75M | $-63M | $-54M | $-38M | $-10M | $37M | $88M | $171M |
| EPS Avg | $-0.58 | $-0.47 | $-0.30 | $-0.21 | $-0.06 | $0.15 | $0.36 | $0.71 |
| Low | $-0.80 | $-0.69 | $-0.38 | $-0.27 | $-0.07 | $0.14 | $0.33 | $0.64 |
| High | $-0.38 | $-0.32 | $-0.27 | $-0.19 | $-0.05 | $0.19 | $0.45 | $0.88 |
| Analysts (Rev / EPS) | 13 / 7 | 13 / 7 | 6 / 3 | 6 / 3 | 6 / 2 | 6 / 2 | 6 / 2 | 5 / 3 |